Application no. and date | 10184711.9 (espacenet) (Federated) (European Patent Register), 20010330 | Patent/reg. no. and date | DK/EP 2345742, 20140611 | Publication date | 20110720 | Priority no. and date | US 193594 P, 20000330, EP 00126325, 20001201, US 265232 P, 20010131 | EP pub. no. and date |
EP 2345742 20110720 | Effective date | | Applicant/owner | Max-Planck-Gesellschaft zur Förderung
der Wissenschaften e.V., Hofgartenstrasse 2
80539 München, DE, University of Massachusetts, 225 Franklin Street, 12th Floor
Boston, MA 02110, US, Massachusetts Institute of Technology, 77 Massachusetts Avenue Cambridge, MA 02139, US, Whitehead Institute for Biomedical Research, Nine Cambridge Center
Cambridge, MA 02142, US | Applicant ref. no. | 14004-9 | Inventor | Sharp, Phillip A, 36 Fairmont Avenue
Newton, MA 02458, US, Bartel, David P, 2 Bowker Street
Brookline, MA 02146, US, Zamore, Philip D, 500 Green Street
Northborough, MA 01532, US, Tuschl, Thomas, Laboratory of RNA Molecular Biology, The Rockefeller University, 1230 York Avenue
New York, NY 10021, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | C12N 15/113 (2010.01) | Title | RNA-sekvensspecifikke formidlere af RNA-interferens | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|